期刊文献+

尼莫地平泊洛沙姆188纳米胶束的制备工艺研究 被引量:3

Study on preparation of nimodipine loaded pluronic 188 nano-micelles
下载PDF
导出
摘要 目的探讨制备尼莫地平泊洛沙姆188纳米胶束的优良工艺。方法采用乳化-溶剂蒸发法制备尼莫地平泊洛沙姆188纳米胶束,考察影响尼莫地平泊洛沙姆188纳米胶束包封率的主要因素,即有机溶剂的种类、尼莫地平溶液滴加速率、有机相与水相的体积比以及尼莫地平与泊洛沙姆188的质量比,并在此基础上采用正交设计优化尼莫地平泊洛沙姆188纳米胶束的制备工艺。结果尼莫地平泊洛沙姆188纳米胶束的制备最优处方为尼莫地平滴加速率为0.2 ml/min,有机相与水相的体积比为1∶5,尼莫地平与泊洛沙姆188的质量比为1∶3。结论通过正交试验,能够获得尼莫地平泊洛沙姆188纳米胶束的最佳制备工艺。 Objective To investigate the superordinary technology of preparing pluronic 188 nano-micelles loaded with nimodipine. Methods Nimodipine loaded pluronic 188 nano-micelles were prepared by emulsifying solvent-evaporation method.The main factors effecting the drug encapsulation ratio were investigated,the factors include the kinds of organic solvent,the dropping rate of nimodipine solution,the volume ratio of organic phase to aqueous phase and the mass ratio of nimodipine to poloxamer 188,on the basis of single-factor experiments,the orthogonal design was carried out to optimize the preparation of nimodipine loaded pluronic 188 nano-micelles. Results The optimal preparation of nimodipine loaded pluronic 188 nano-micelle was: the nimodipine dropping rate was 0.2 ml/min,the volume ratio of organic phase to aqueous phase was 1∶5 and the mass ratio of nimodipine to poloxamer 188 was 1∶3. Conclusion Superordinary technology of preparing nimodipine loaded pluronic 188 nano-micelles can be obtained by orthogonal design.
作者 牛江秀 杨雪
出处 《中国当代医药》 2015年第1期4-7,共4页 China Modern Medicine
基金 安徽省自然科学基金项目(1308085QH139)
关键词 乳化-溶剂蒸发法 尼莫地平 包封率 正交试验 Emulsion-solvent evaporation method Nimodipine Encapsulation efficiency Orthogonal
  • 相关文献

参考文献15

二级参考文献115

共引文献135

同被引文献54

  • 1张晓君,王东凯,韩晓.聚合物胶束作为药物传递系统的研究进展[J].中国药剂学杂志(网络版),2009(3):177-183. 被引量:18
  • 2XIONG R, LU W, LI J, et al. Preparation and characterization of intravenously injectable nimodipine nanosuspension [ J ]. In- ternational Journal of Pharmaceutics, 2008, 350 ( 2 ) : 338 - 343.
  • 3KTISTIS G. FDA warns of serious harm from IV administration of nimodipine [ J ]. Reactions Weekly, 2013, 1313 ( 1 ) : 4 - 5.
  • 4KARAVAS E, KTISTIS G, XENAKIS A, et al. Effect of hydro- gen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone [ J ]. European Journal of Pharmaceutics and Biopharmaceutics, 2006, 63 ( 2 ) : 103 - 114.
  • 5ANNA K, BARTOMIEJ M, KACPER D, et al. Mesoporous drug carrier systems for enhanced delivery rate of poorly water - soluble drug: nimodipine. Journal of Porous Materials, 2015, 22 (3) : 817 -829.
  • 6ZHENG X, YANG R, TANG X, et al. Part I : characterization of solid dispersions of nimodipine prepared by hot - melt extru- sion [ J ]. DrugDevelopment and Industrial Pharmacy, 2007, 33 : 791 - 802.
  • 7MULLER R H, RADTKE M, WISSING S A. Nanostructured lipid matrices for improved microencapsulation of drugs [ J ]. International Journal of Pharrnaceutics, 2002, 242 ( 1 - 2 ) : 121 - 128.
  • 8NEPAL P R, HAN H K, CHOI H K. Preparation and invitro - in vivo evaluation of witepsol H35 based self - nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q (10) [ J ]. European Journal of Pharmaceutical Sciences, 2010, 39 (4) : 224 - 232.
  • 9JYOTHI N V, PRASANNA P M, SAKARKAR S N, et al. Mi- croencapsu]ation techniques, factors influencing encapsulation efficiency [ J]. Journal of Mieroencapsulation, 2010, 27 ( 3 ) : 187 - 197.
  • 10肖莉,张韵慧,崔颖,晋兴华,李培凡.尼莫地平聚乳酸缓释微球的制备及其药剂学性质[J].中国医院药学杂志,2008,28(3):194-198. 被引量:10

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部